Veterinary Medicines

Canergy 100 mg Tablets for Dogs

Authorised
  • Propentofylline
Download as PDF

Product identification

Medicine name:
Canergy 100 mg Tablets for Dogs
Canergy 100 mg Tablet
Canergy 100 mg Comprimé
Canergy 100 mg Tablette
Active substance:
  • Propentofylline
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Propentofylline
    100.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC04AD90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Cardboard box with 7 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 6 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 50 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 5 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 4 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 3 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 25 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 2 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 10 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 1 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 9 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 8 Aluminium - PA_ALU_PVC blister of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Artesan Pharma GmbH & Co. KG
  • Lelypharma B.V.
  • GENERA d.d.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V477297
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0313/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 17/08/2025
Download
German (PDF)
Published on: 17/08/2025
Download